<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00629291</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-07-4859-OG-CTIL</org_study_id>
    <nct_id>NCT00629291</nct_id>
  </id_info>
  <brief_title>MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.</brief_title>
  <official_title>Evaluation of Iron Overload in the Heart, Liver and Pancreas: Patients With Sickle β Thalassemia and Sickle Cell Anemia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sickle cell anemia and Sickle cell β thalassemia patients require multiple transfusions in
      order to avoid chronic anemia sequel. This regimen entails intrinsic deleterious effects, the
      majority of which are related to iron deposition in the reticuloendothelial system. Thus,
      iron is deposited in hepatic, myocardial and endocrine glands tissues. Tools available for
      iron load evaluation include serum ferrtin levels, liver biopsy and echocardiography, all are
      non specific.

      The purpose of this work is to compare iron overload in the liver, heart and pancreas in
      Sickle cell anemia and Sickle cell β thalassemia patients using T2* MRI sequences.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sickle cell anemia and Sickle cell β thalassemia patients recieving multiple transfusions are
      exposed to the effects of iron deposition in the reticuloendothelial system, including
      cardiac muscle, liver and pancreas. Tools available for iron load evaluation include serum
      ferrtin levels, liver biopsy and echocardiography, all are non specific.

      The purpose of this work is to compare iron overload in the liver, heart and pancreas in
      Sickle cell anemia and Sickle cell β thalassemia patients using T2* MRI sequences.

      Patients and Methods: 27 Sickle cell anemia and 28 Sickle cell β thalassemia will undergo
      transthoracic echocardiography, cardiac MRI using T2* sequences and clinical and laboratory
      evaluation for iron overload including ferritin levels and oral glucose tolerance test
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>outcome measure: iron overload on T2* MRI in the heart , liver and pancreas.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Iron Overload</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Sickle cell anemia patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Sickle cell β thalassemia</description>
  </arm_group>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      No biosepcimens retained
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Sickle cell anemia and Sickle cell β thalassemia patients from dedicated outpatient
        hospital clinic.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of Sickle cell anemia or Sickle cell β thalassemia having received
             multiple blood transfusions.

        Exclusion Criteria:

          -  contraindication to MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orly Goitein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sheba Medical Center , Imaging Dept</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2008</study_first_submitted>
  <study_first_submitted_qc>February 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2008</study_first_posted>
  <last_update_submitted>May 9, 2010</last_update_submitted>
  <last_update_submitted_qc>May 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Orly Goitein MD</name_title>
    <organization>Sheba medical center</organization>
  </responsible_party>
  <keyword>iron overload</keyword>
  <keyword>Thalassemia</keyword>
  <keyword>Anemia, Sickle Cell</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron Overload</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

